Pyxis Total Assets from 2010 to 2024

PYXS Stock

USD 2.00 0.01 0.50%

Pyxis Oncology Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 152.9 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

173.7 M

Current Value

152.9 M

Quarterly Volatility

88.8 M

Credit Downgrade

Yuan Drop

Covid

Check Pyxis Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pyxis Oncology's main balance sheet or income statement drivers, such as Net Interest Income of 7.3 M, Interest Income of 7.3 M or Depreciation And Amortization of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.6. Pyxis financial statements analysis is a perfect complement when working with Pyxis Oncology Valuation or Volatility modules.

Check out the analysis of Pyxis Oncology Correlation against competitors.

For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.

Latest Pyxis Oncology's Total Assets Growth Pattern

Below is the plot of the Total Assets of Pyxis Oncology over the last few years. Total assets refers to the total amount of Pyxis Oncology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pyxis Oncology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Pyxis Oncology's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pyxis Oncology's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 173.73 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Pyxis Total Assets Regression Statistics

	Arithmetic Mean	68,417,699
	Geometric Mean	35,055,126
	Coefficient Of Variation	129.83
	Mean Deviation	72,583,158
	Median	19,807,000
	Standard Deviation	88,829,339
	Sample Variance	7890.7T
	Range	269.9M
	R-Value	0.69
	Mean Square Error	4478.1T
	R-Squared	0.47
	Significance	0
	Slope	13,660,866
	Total Sum of Squares	110469.1T

Pyxis Total Assets History

	2024	152.9 M
	2023	173.7 M
	2022	211.4 M
	2021	280 M
	2020	10.2 M

Other Fundumenentals of Pyxis Oncology

Intangibles To Total Assets

Pyxis Oncology Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Capital Surpluse	Net Receivables	Intangible Assets
Total Assets		1.0	0.99	0.91	-0.73	-0.77	0.97	0.56	1.0	0.99	0.93	0.98	0.67	0.93	0.66	0.53	-0.43	-0.39
Total Stockholder Equity	1.0		0.99	0.87	-0.77	-0.71	0.98	0.47	1.0	1.0	0.89	0.99	0.6	0.89	0.59	0.47	-0.39	-0.36
Net Tangible Assets	0.99	0.99		0.92	-0.7	-0.76	0.95	0.54	0.99	0.97	0.94	0.96	0.65	0.94	0.64	0.58	-0.47	-0.39
Current Deferred Revenue	0.91	0.87	0.92		-0.48	-0.89	0.81	0.8	0.87	0.85	0.99	0.81	0.84	0.99	0.83	0.76	-0.59	-0.47
Net Debt	-0.73	-0.77	-0.7	-0.48		0.14	-0.83	-0.02	-0.77	-0.8	-0.46	-0.83	-0.03	-0.46	-0.02	0.17	-0.28	-0.27
Retained Earnings	-0.77	-0.71	-0.76	-0.89	0.14		-0.63	-0.87	-0.71	-0.69	-0.91	-0.64	-0.98	-0.91	-0.98	-0.91	0.84	0.79
Accounts Payable	0.97	0.98	0.95	0.81	-0.83	-0.63		0.38	0.98	0.99	0.81	0.99	0.52	0.81	0.5	0.34	-0.28	-0.29
Total Liab	0.56	0.47	0.54	0.8	-0.02	-0.87	0.38		0.47	0.45	0.78	0.38	0.92	0.78	0.92	0.82	-0.63	-0.52
Net Invested Capital	1.0	1.0	0.99	0.87	-0.77	-0.71	0.98	0.47		1.0	0.89	0.99	0.6	0.89	0.59	0.47	-0.39	-0.36
Total Current Assets	0.99	1.0	0.97	0.85	-0.8	-0.69	0.99	0.45	1.0		0.86	1.0	0.58	0.86	0.56	0.42	-0.34	-0.33
Capital Stock	0.93	0.89	0.94	0.99	-0.46	-0.91	0.81	0.78	0.89	0.86		0.83	0.84	1.0	0.83	0.79	-0.66	-0.53
Net Working Capital	0.98	0.99	0.96	0.81	-0.83	-0.64	0.99	0.38	0.99	1.0	0.83		0.52	0.83	0.51	0.37	-0.3	-0.3
Short Term Debt	0.67	0.6	0.65	0.84	-0.03	-0.98	0.52	0.92	0.6	0.58	0.84	0.52		0.84	1.0	0.9	-0.83	-0.79
Common Stock	0.93	0.89	0.94	0.99	-0.46	-0.91	0.81	0.78	0.89	0.86	1.0	0.83	0.84		0.83	0.79	-0.66	-0.53
Property Plant Equipment	0.66	0.59	0.64	0.83	-0.02	-0.98	0.5	0.92	0.59	0.56	0.83	0.51	1.0	0.83		0.9	-0.83	-0.79
Capital Surpluse	0.53	0.47	0.58	0.76	0.17	-0.91	0.34	0.82	0.47	0.42	0.79	0.37	0.9	0.79	0.9		-0.94	-0.8
Net Receivables	-0.43	-0.39	-0.47	-0.59	-0.28	0.84	-0.28	-0.63	-0.39	-0.34	-0.66	-0.3	-0.83	-0.66	-0.83	-0.94		0.94
Intangible Assets	-0.39	-0.36	-0.39	-0.47	-0.27	0.79	-0.29	-0.52	-0.36	-0.33	-0.53	-0.3	-0.79	-0.53	-0.79	-0.8	0.94

Click cells to compare fundamentals

About Pyxis Oncology Financial Statements

Pyxis Oncology shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Pyxis Oncology investors may analyze each financial statement separately, they are all interrelated. The changes in Pyxis Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pyxis Oncology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	173.7 M	152.9 M
Intangibles To Total Assets	0.13	0.11

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Pyxis Stock Analysis

When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC